Summit Partners Public Asset Management’s Constellation Energy CEG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-80,000
Closed -$22.3M 171
2026
Q1
$22.3M Sell
80,000
-20,000
-20% -$6.08M 0.6% 57
2025
Q4
$35.3M Sell
100,000
-30,000
-23% -$10.9M 0.73% 52
2025
Q3
$42.8M Buy
+130,000
New +$42M 0.89% 39
2025
Q2
Sell
-150,000
Closed -$30.2M 144
2025
Q1
$30.2M Sell
150,000
-65,000
-30% -$17.4M 0.78% 47
2024
Q4
$48.1M Buy
215,000
+115,000
+115% +$28.7M 0.92% 37
2024
Q3
$26M Sell
100,000
-260,000
-72% -$51.7M 0.81% 41
2024
Q2
$72.1M Buy
360,000
+60,000
+20% +$12.2M 2.75% 7
2024
Q1
$55.5M Buy
+300,000
New +$42.6M 1.91% 13

Other funds holding CEG

Summit Partners Public Asset Management's CEG Position: Q2 2026 in Review

Summit Partners Public Asset Management increased its Constellation Energy (CEG) stake by 25% in Q2 2026, buying an estimated $5.63M and bringing the position to 100,000 shares worth $24.8M. The position accounts for 0.44% of the portfolio, ranked #67.

Summit Partners Public Asset Management first reported a position in CEG in Q1 2024 and has held it in 10 quarters since. The position peaked at $84.3M in Q1 2024. 1,862 funds tracked by Wall St. Rank hold CEG as of Q2 2026.

  • Summit Partners Public Asset Management held 100,000 shares of Constellation Energy worth $24.8M as of Q2 2026.
  • Summit Partners Public Asset Management bought 20,000 Constellation Energy shares in Q2 2026, an estimated $5.63M.
  • Constellation Energy made up 0.44% of Summit Partners Public Asset Management's portfolio in Q2 2026, its #67 holding.
  • Summit Partners Public Asset Management first reported a position in Constellation Energy in Q1 2024 and has held it in 10 quarters since.
  • Summit Partners Public Asset Management's Constellation Energy position peaked at $84.3M in Q1 2024.
  • 1,862 funds tracked by Wall St. Rank held Constellation Energy as of Q2 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.